Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company is mainly engaged in selling health supplements and providing original equipment manufacturing (OEM) services. The Company also outsources manufacturing / OEM services.

Employees

Sector

Pharmaceuticals

More about the company

Income Statement and Estimates

More financial data

Market Closed - OTC Markets Other stock markets 10:39:26 2026-06-23 EDT			5-day change	1st Jan Change
0.2703 ^USD	+48.60%		-.--%	+350.50%

05-18	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	14.54M 12.71M 11.68M 10.89M 20.66M 1.38B 20.97M 140M 54.53M 681M 54.59M 53.42M 2.35B	P/E 2024	-7x	P/E 2025	2.54x
Enterprise Value	16.11M 14.08M 12.94M 12.06M 22.88M 1.53B 23.23M 155M 60.39M 754M 60.46M 59.16M 2.6B	EV / Sales 2024	36.6x	EV / Sales 2025	2.03x
Free-Float	26.52%	Yield 2024 *	-	Yield 2025	-

05-18	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-24	Bio Essence Corporation has entered into a Asset Purchase Agreement to acquire MediFlow AI from Zhituo Software Co., Limited for $3.1 million.	CI
03-27	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-26	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
11-12	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-28	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-03-27	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
24-11-14	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-19	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-06-21	Bio Essence Corporation Announces Board Changes	CI

11-12	Bio Essence : Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q)	PU
24-10-07	Bio Essence : Amendment to Quarterly Report Form 10 Q/A	PU
24-10-07	Bio Essence : Non Reliance of Financial Report Form 8 K	PU
23-03-30	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
22-05-16	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ

Bio Essence Corporation Stock

Stocks

BIOE

US09090C1053

Pharmaceuticals

Valuation: Bio Essence Corporation

Chart: Bio Essence Corporation

Latest news : Bio Essence Corporation

Press Releases: Bio Essence Corporation

Quotes and Performance

Course Extremes

Managers and Directors: Bio Essence Corporation

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Income Statement and Estimates

1 day	+48.60%
1 month	-1.35%
3 months	+46.42%
6 months	+350.50%
Current year	+350.50%

1 month	0.18	0.43
Current year	0.05	0.52
1 year	0.05	0.52
3 years	0.05	10.81
5 years	0.05	10.81
10 years	0.05	10.81

Manager	Title	Age	Since
Yin Yan CEO	Chief Executive Officer	50	-
Bill Sluss DFI	Director of Finance/CFO	71	2023-09-06
Tuan Tran COO	Chief Operating Officer	52	2017-12-31

Director	Title	Age	Since
Bill Sluss BRD	Director/Board Member	71	2024-06-17
Yin Yan CHM	Chairman	50	-
Siyavash Fooladian BRD	Director/Board Member	54	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
24-10-27	Yin Yan	Sell	Chief Executive Officer	323,845	0.8520%
24-07-10	Yin Yan	Sell	Chief Executive Officer	92,190	0.2425%
24-07-01	Yin Yan	Sell	Chief Executive Officer	60,274	0.1586%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIO ESSENCE CORPORATION	+48.60%	-.--%	+184.53%	-47.00%	14.54M
ELI LILLY AND COMPANY	+1.86%	+0.48%	+55.50%	+163.08%	1,082B
JOHNSON & JOHNSON	+3.57%	+3.29%	+68.60%	+61.03%	633B
ABBVIE INC.	+3.99%	+3.05%	+37.93%	+93.37%	461B
ROCHE HOLDING AG	+3.86%	+1.64%	+32.57%	+24.89%	338B
ASTRAZENECA PLC	-0.56%	+0.96%	+41.67%	+39.35%	299B
NOVARTIS AG	-0.08%	+1.30%	+32.15%	+44.48%	291B
NOVO NORDISK A/S	-1.54%	+2.81%	-25.35%	-39.61%	222B
AMGEN INC.	+3.55%	+4.41%	+25.45%	+66.28%	202B
GILEAD SCIENCES, INC.	+4.21%	+2.65%	+17.47%	+71.11%	163B
Average	+6.75%	+4.12%	+47.05%	+47.70%	369.24B
Weighted average by Cap.	+2.25%	+5.53%	+42.31%	+83.31%

	2024	2025
Net sales	324K 283K 260K 243K 460K 30.84M 467K 3.12M 1.21M 15.16M 1.22M 1.19M 52.24M	1.9M 1.66M 1.52M 1.42M 2.7M 181M 2.74M 18.3M 7.11M 88.81M 7.12M 6.97M 306M
Net income	-1.31M -1.14M -1.05M -980K -1.86M -125M -1.89M -12.62M -4.91M -61.26M -4.91M -4.81M -211M	896K 783K 720K 671K 1.27M 85.33M 1.29M 8.64M 3.36M 41.94M 3.36M 3.29M 145M
Net Debt	2.7M 2.36M 2.17M 2.02M 3.84M 257M 3.9M 26.07M 10.14M 127M 10.15M 9.93M 436M	1.56M 1.37M 1.26M 1.17M 2.22M 149M 2.25M 15.08M 5.86M 73.15M 5.87M 5.74M 252M